Novartis to buy experimental breast cancer drug in up to $3 billion deal
Novartis to buy experimental breast cancer drug in up to $3 billion deal
Related Posts
Popular News
Latest News
XRP Network Activity Hits 3-Month High After Leverage Flush
Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure XRP network activity is improving after a...
Alibaba-affiliate Ant Group enters the humanoid robot market with 12 deals
Zeroth W1, produced by Lexiang Technology, has obtained the Wall-E IP authorization for the Disney animated film "RoboCop" and will...
10 Hacks Every MacBook Air User Should Know
We may earn a commission from links on this page. Apple's MacBook Air is a great value—even now, after the...
Tradeweb Completes Tokenized US Treasury Trade on Canton
Tradeweb, an institutional electronic trading platform, has executed an onchain transaction involving tokenized US Treasuries, with Franklin Templeton transferring a...
Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.